Condition (MeSH)
Thrombophlebitis
ClinicalTrials.gov lists 13 trials for Thrombophlebitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
13 of the 13 trials are tagged with Thrombophlebitis itself; the rest are tagged with a narrower condition beneath it.
When did Thrombophlebitis trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2022 | 2 |
| 2021 | 1 |
| 2015 | 1 |
| 2013 | 1 |
| 2010 | 1 |
| 2006 | 1 |
| 2005 | 1 |
| 1998 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 13 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Thrombophlebitis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 5 |
| Phase 4 | 1 |
| Not applicable | 3 |
| Observational | 3 |
How many Thrombophlebitis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Completed | 9 |
| Terminated | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Thrombophlebitis trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Medinova AG | 1 |
| Mucos Pharma GmbH & Co. KG | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Western Galilee Hospital-Nahariya | 1 |
Which drugs are being tested for Thrombophlebitis? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| (LMW)heparin | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Warfarin VKA | 2 |
| LMWH parnaparin subcutaneously | 1 |
| Recombinant Tissue Plasminogen Activator | 1 |
| Phlogenzym | 1 |
| Fragmin P Forte (dalteparin sodium) | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Thrombophlebitis? (216)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Peripheral Vein Thrombophlebitis in the Upper Extremity: A Systematic Review of a Frequent and Important Problem. | The American journal of medicine | 2020 | Yes |
| Treatment for superficial thrombophlebitis of the leg. | The Cochrane database of systematic reviews | 2018 | Yes |
| A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam. | Infection | 2018 | Yes |
| A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities. | Phlebology | 2017 | Yes |
| A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. | Journal of thrombosis and haemostasis : JTH | 2012 | Yes |
Showing 5 of 216 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.